GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$945M
AUM Growth
+$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$52M
2
+$46.4M
3
+$37.9M
4
ZYME icon
Zymeworks
ZYME
+$35.1M
5
DXCM icon
DexCom
DXCM
+$23.5M

Top Sells

1
+$28M
2
+$22.3M
3
+$15.3M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$5.02M
5
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$3.52M

Sector Composition

1 Healthcare 98.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$8.36M 0.88%
+222,222
27
$7.4M 0.78%
22,945
-1,137
28
$7.31M 0.77%
+129,424
29
$7.06M 0.75%
+20,000
30
$5.48M 0.58%
+309,700
31
$2.96M 0.31%
25,000
32
$1.69M 0.18%
+325,000
33
$193K 0.02%
+92,140
34
$141K 0.01%
8,676
35
– –
0
36
– –
-184,266
37
– –
-926,933
38
– –
-547,712
39
– –
-2,110,071
40
– –
0
41
– –
-350,000
1
2